Clinical and genetic evaluations of the family members revealed that only four of the 11 individuals who carried the p.V654L mutation in one RB1 allele developed unilateral retinoblastoma, yielding a penetrance of only 36%. This evidence concerns the gene RB1 and retinoblastoma.